[Chinese expert-based consensus for methotrexate in rheumatic diseases].

To establish the experts consensus on the use of methotrexate in the treatment of rheumatic diseases. A consensus development panel was established. The panel of consensus was composed of 45 experts in rheumatology from the group of Chinese Association of Rheumatology and Immunology Physicians. The consensus development panel developed 7 recommendations, including the clinical status and application principles of methotrexate in the treatment of rheumatoid arthritis, optimal dosage and route, dosage adjustment, monitoring, long-term safety and management in the perioperative period and before/during pregnancy. This consensus was intended to standardize the use of methotrexate in rheumatic diseases and improve the management of rheumatoid arthritis and other rheumatic diseases.